Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 12/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18618861 | 0.84 | DHFR (0.67) | DHFRPKM | |
| SCHEMBL5214698 | 0.82 | DHFR (0.63) | DHFR | |
| SCHEMBL5213984 | 0.79 | BACE1 (0.63) | DHFR | |
| SCHEMBL18621217 | 0.76 | DHFR (0.63) | DHFRTSHR | |
| SCHEMBL5215414 | 0.75 | DHFR (0.48) | DHFR | |
| SCHEMBL13687772 | 0.74 | DHFR (0.56) | DHFRTSHR | |
| SCHEMBL2903758 | 0.73 | TSHR (0.56) | DHFRTSHR | |
| SCHEMBL8265248 | 0.72 | BACE1 (0.67) | DHFRTSHR | |
| SCHEMBL720798 | 0.72 | CYP2D6 (0.58) | DHFRTSHR | |
| SCHEMBL11050996 | 0.72 | KDM4E (0.60) | DHFRTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1831170-A1 | SUBSTITUTED AMINOPYRIDINES AND USES THEREOF | AstraZeneca AB (SE) | 2007-09-12 | — | — | EP | claimed |
| WO-2006065204-A1 | SUBSTITUTED AMINOPYRIDINES AND USES THEREOF | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | claimed |
| EP-1831170-A1 | SUBSTITUTED AMINOPYRIDINES AND USES THEREOF | AstraZeneca AB (SE) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006065204-A1 | SUBSTITUTED AMINOPYRIDINES AND USES THEREOF | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |